Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
COVID has highlighted the differences in healthcare affordability across the globe, with a glimpse into what the future of medicine could look like if we don’t act. The experience…
By Pharmatrax Author
Category: News
No Comments
Solving problems during a crisis demands speeding up innovation by repurposing the knowledge, resources, and technology you already have at hand. The coronavirus pandemic is…
By Pharmatrax Author
No Comments
Lincoln Laboratory researchers join an international task force to evaluate wearable and emerging technology. Caption: Wearable devices are viable options to monitor Covid-19 patients and…
By Pharmatrax Author
Category: News
No Comments
Drug Target Review rounds up the latest announcements regarding funding for research into COVID-19 treatments and vaccines. The world has mobilized its efforts to research potential…
By Pharmatrax Author
Category: Technoloy
No Comments
Keith Murphy, CEO of Viscient Biosciences, discusses the process of developing a 3D bioprinted tissue model and their potential in developing therapeutics for COVID-19 and…
By Pharmatrax Author
Category: Technoloy
No Comments
The Digital Technology Senate themed around “How India Inc. is fighting Covid-19: Innovation in Disruptive Times” kick started on June 2, 2020 amidst a virtual…
By Pharmatrax Author
Category: News
No Comments
Since the early days of the Covid-19 pandemic, world-class hospitals from New York to Atlanta to San Francisco struggled with shortages of basic safety equipment.…
By Pharmatrax Author
Category: Technoloy
No Comments
Perhaps the best part about covering technology is the opportunity to learn about innovations as they occur. Some (most actually) never get the opportunity to…
By Pharmatrax Author
Category: Technoloy
No Comments
Often, a crisis brings about a re-evaluation of basic systems. As the world wrestles with the multi-faceted impacts of COVID-19, the global supply chain has…
By Pharmatrax Author
Category: News
No Comments
On the hunt for drugs contaminated with a likely carcinogen, the FDA initially tested and cleared generic diabetes med metformin. But now, after an independent lab…